The chronic hyperproliferative diseases (CHD) include cancer, precancerous lesions and diseases of unknown etiology such as
psoriasis. Various drugs have been used in the treatment of CHD, such as antiproliferative and corticosteroids in general. However, some
drugs have properties that limit their effectiveness, such as low solubility in water and low penetration of the skin. Thus, the control of
drug release in the skin may improve efficacy and reduce side effects of many drugs used in hyperproliferative diseases. The purpose of
this study was to make a systematic review of nanotechnology-based drug delivery systems used against hyperproliferative skin diseases.
Keywords: Chronic hyperoproliferative diseases, drug delivery systems, nanotechnology, skin diseases, skin treatment, skin cancer, psoriasis
Rights & PermissionsPrintExport